These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3283652)

  • 1. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
    Gai XX; Rizzo MG; Valpreda S; Baserga R
    Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of c-myc transcription involves myc family proteins.
    Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR
    Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
    Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
    Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
    Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
    Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF beta inhibits Go/S-phase transition in primary fibroblasts. Loss of response to the antigrowth effect of TGF beta is observed after immortalization.
    Sorrentino V; Bandyopadhyay S
    Oncogene; 1989 May; 4(5):569-74. PubMed ID: 2498805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
    Yaar M; Peacocke M; Cohen MS; Gilchrest BA
    J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
    Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat fibroblasts expressing high levels of human c-myc transcripts are anchorage-independent and tumorigenic.
    Pellegrini S; Basilico C
    J Cell Physiol; 1986 Jan; 126(1):107-14. PubMed ID: 3944192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M; Wu LT; LeRoy EC
    Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
    Cory JG; He AW; Cory AH
    Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.